Search results
Results from the WOW.Com Content Network
[18] 30.4–88.9% of those with antisynthetase syndrome report persistent muscular tenderness and myalgia. [19] [20] In antisynthetase syndrome, arthritis is commonly described as a symmetrical, non-erosive polyarthritis of the small hands and feet that can sometimes mimic CTD-associated, rheumatoid, and seronegative inflammatory arthritis. [21]
PM/Scl overlap syndrome Scleromyositis , is an autoimmune disease (a disease in which the immune system attacks the body). People with scleromyositis have symptoms of both systemic scleroderma and either polymyositis or dermatomyositis , and is therefore considered an overlap syndrome .
Anti-Jo1 has been associated with inflammatory myopathies such as polymyositis, dermatomyositis and antisynthetase syndrome. [ 3 ] [ 4 ] It has histidine-tRNA ligase as a target.
Hematologic: Aplastic anemia, chronic neutropenia, monocytopenia, monocytosis (rarely), thrombocytopenia (which unlike other hematologic findings is most often due to autoimmunity), bone marrow failure, myelodysplastic syndrome, acute myeloid leukemia, chronic myelomonocytic leukemia, case reports of chronic lymphocytic leukemia and large ...
Myelophthisic anemia (or myelophthisis) is a severe type of anemia found in some people with diseases that affect the bone marrow. Myelophthisis refers to the displacement of hemopoietic bone-marrow tissue [1] by fibrosis, tumors, or granulomas. The word comes from the roots myelo-, which refers to bone marrow, and phthisis, shrinkage or atrophy.
Traumatic hemolytic anemia [2] Impact [2] Macrovascular defects-prostheses [2] Microvascular causes [2] Disseminated intravascular hemolysis [2] Thrombotic thrombocytopenic purpura [2] Typical and atypical hemolytic uremic syndrome [2] Other microvascular abnormalities; Hypersplenism [2] Hemolytic anemia due to toxic effects on the membrane ...
Diabetes, a condition where blood glucose levels cannot be controlled, affects more than 10% of the adult population worldwide, and more than 90% of those have type 2 diabetes.
Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare autosomal recessive bone marrow failure syndrome characterized by severe thrombocytopenia, which can progress to aplastic anemia and leukemia. [4] CAMT usually manifests as thrombocytopenia in the initial month of life or in the fetal phase.